Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy
Sun Ae Han, Young Min Yoon, Wan Soo Lee, Yun Sung Kim, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim
Korean J Intern Med. 2016;31(3):601-604. Published online 2016 Mar 7 DOI: https://doi.org/10.3904/kjim.2014.292
Citations to this article as recorded by 
Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts
Helen L Leavis, Paul L A van Daele, Catharina Mulders-Manders, Renée Michels, Abraham Rutgers, Elizabeth Legger, Marc Bijl, Elisabeth A Hak, Wai-Kwan Lam-Tse, Femke Bonte-Mineur, Peter Fretter, Anna Simon, Pieter van Paassen, Marlies C van der Goes, Marce
Rheumatology.2023;[Epub] CrossRef
Secondary Amyloidosis Presenting as Ischemic Proctitis
Saad Hashmi, Assad Munis, Ryan T. Hoff, Hymie Kavin, Eli D. Ehrenpreis, Haruhiko Sugimura
Case Reports in Gastrointestinal Medicine.2021; 2021: 1. CrossRef
Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
Ayush Gupta, Narendra Kumar Bagri, Saroj Kumar Tripathy, Adarsh Barwad, Ravi Hari Phulware, Pankaj Hari
Rheumatology International.2020; 40(1): 153. CrossRef